Unknown PHASE2 INTERVENTIONAL 2-arm NCT05014594

Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh

Interventions Dapagliflozin (10Mg Tab) along with standard medical therapy Placebo of dapaglifozin along with standard medical therapy

Updated 7 times since 2021 Last updated: Sep 3, 2021 Started: Sep 3, 2021 Primary completion: May 19, 2022 Completion: May 19, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Ascites Hepatic and Cirrhosis, this trial is ongoing. The trial is conducted by Post Graduate Institute of Medical Education and Research, Chandigarh and has accumulated 7 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Jul 2025 — Present [monthly]

Unknown PHASE2
Sep 2024 — Jul 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Apr 2024 — Jul 2024 [monthly]

Unknown Status PHASE2
Oct 2023 — Apr 2024 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Oct 2021 — Oct 2023 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Sep 2021 — Oct 2021 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Post Graduate Institute of Medical Education and Research, Chandigarh

Data source: Post Graduate Institute of Medical Education and Research, Chandigarh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chandigarh, India